跳转至内容
Merck
CN

Recalcitrant hypocalcaemia in autoimmune enteropathy.

Pediatrics (2014-11-19)
Myfanwy Geyer, Jan Fairchild, David Moore, Lynette Moore, Paul Henning, Elaine Tham
摘要

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy syndrome is a monogenic disorder associated with autoimmune destruction of both endocrine and nonendocrine tissues. The classic triad includes candidiasis, hypoparathyroidism, and Addison disease. Up to 25% of patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy syndrome also have gastrointestinal manifestations, which can have an impact on the management of other aspects of the disease. The management of the case discussed was challenging because of the complex interplay between the manifestations and treatment of his hypoparathyroidism, Addison disease, and autoimmune enteropathy. Attempts at management of hypocalcemia were largely unsuccessful until the introduction of immunosuppressive therapy for autoimmune enteropathy. This case supports early consideration of immunosuppression in this condition.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
1α,25-二羟基维生素D3, ≥99% (HPLC)
Sigma-Aldrich
柠檬酸钙四水合物, 99%
Supelco
环孢菌素A 溶液, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
1α,25-二羟基维生素D3, ≥97.0% (HPLC)
Sigma-Aldrich
硫唑嘌呤, ≥98%
Supelco
1α,25-二羟基维生素D3标准液 CRM 溶液, 5 μg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®
骨化三醇, European Pharmacopoeia (EP) Reference Standard
Supelco
硫唑嘌呤, Pharmaceutical Secondary Standard; Certified Reference Material
硫唑嘌呤, European Pharmacopoeia (EP) Reference Standard